Gender Affirming Vaginoplasty With Tubularized Augmented Peritoneal Cap (TAPCap) Utilizing Fish Skin Xenograft (Kerecis™)
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- University Hospitals Cleveland Medical Center
- Study ID
- NCT07286123
- Status
- Recruiting
Conditions
- Gender Dysphoria, Adult
Eligibility Criteria
- Sex
- MALE
- Age
- 19 Years - 99 Years
- Healthy Volunteers
- Not accepted
Interventions
- Tubularized augmented peritoneal cap vaginoplasty — PROCEDUREIn this surgery, the distal portion of the neovagina is constructed using inverted penile skin, the proximal portion is made of peritoneal tissue. The area in between peritoneal tissue and penile skin is lined with the Kerecis graft in this standard of care surgery.
- Biopsy — PROCEDUREBiopsies will be obtained at 6 months post-op from the distal, middle, and proximal portions of the neovagina.
Study Details
Bottom gender affirming surgery is one of the key steps towards aligning the physical appearance and gender identity in transgender women. This surgery not only helps in reducing gender dysphoria but also significantly improves the quality of life and psychological well-being of the patients. The basic steps of bottom surgery typically involve the creation of a vagina using the skin from genital organs like the testes and penis, construction of the clitoris and labia. This complex surgery aims to create a functional and aesthetically pleasing vaginal canal that allows for sexual activity, urinary function, and a natural appearance. As part of routine care, a special graft (skin-like material) called Kerecis™ is used to line the middle part of the vagina. It is made from North Atlantic cod skin that is treated in the laboratory and made suitable for surgery purposes. It can be used instead of skin. This graft has been given permission by the Food and Drug Administration (FDA) for marketing the US. This study aims to identify changes in healing parameters following Kerecis™ based vaginoplasty. Up to 20 participants for this study. Participants will be asked to fill out study questionnaires during follow-up visits at post-op week 2, week 12, month , and year 1. At the 6 month post-op follow up, punch biopsies will be obtained from the deepest part, middle part, and the vaginal part most near to the vaginal opening parts to check the healing process using a microscope. The punch biopsies will be 1/8th inch x 1/8th inch each.
Key Dates
- Start date
- Jul 22, 2025
- Status verified
- Dec 2025
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 20 participants (estimated)
Arms
- Arm: Individuals receiving vaginoplastyIndividuals requiring graft-based vaginoplasty
Primary Outcome Measure
Degree of Neovaginal Epithelialization [ Time Frame: Six months post-op ]
Central Contacts
- Seyed Sajjad Tabei, MD216-844-8963
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 |
Find similar trials in Cleveland, OH
Related Studies
- MaPGAS Decision MakingEnrolling By Invitation · Dartmouth-Hitchcock Medical Center · Hanover, New Hampshire
- Can 3D Modeling Enhance Patient Understanding, Education, and Surgical Outcomes in Gender Affirming Peritoneal Vaginoplasty?Not Yet Recruiting · University of Chicago · Chicago, Illinois